These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22684157)

  • 1. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age.
    Wadhawan R; Oh W; Vohr BR; Saha S; Das A; Bell EF; Laptook A; Shankaran S; Stoll BJ; Walsh MC; Higgins R
    Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F127-32. PubMed ID: 22684157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation.
    Attridge JT; Clark R; Gordon PV
    J Perinatol; 2006 Nov; 26(11):667-70. PubMed ID: 17024144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
    Grosfeld JL; Chaet M; Molinari F; Engle W; Engum SA; West KW; Rescorla FJ; Scherer LR
    Ann Surg; 1996 Sep; 224(3):350-5; discussion 355-7. PubMed ID: 8813263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation.
    Shah TA; Meinzen-Derr J; Gratton T; Steichen J; Donovan EF; Yolton K; Alexander B; Narendran V; Schibler KR
    J Perinatol; 2012 Jul; 32(7):552-8. PubMed ID: 22157625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal Steroids, Prophylactic Indomethacin, and the Risk of Spontaneous Intestinal Perforation.
    Laptook AR; Weydig H; Brion LP; Wyckoff MH; Arnautovic TI; Younge N; Oh W; Chowdhury D; Keszler M; Das A;
    J Pediatr; 2023 Aug; 259():113457. PubMed ID: 37172814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates.
    Paquette L; Friedlich P; Ramanathan R; Seri I
    J Perinatol; 2006 Aug; 26(8):486-92. PubMed ID: 16791261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Mar; 26(3):185-8. PubMed ID: 16493433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
    Yang CZ; Lee J
    World J Pediatr; 2008 May; 4(2):91-6. PubMed ID: 18661761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis.
    Wadhawan R; Oh W; Hintz SR; Blakely ML; Das A; Bell EF; Saha S; Laptook AR; Shankaran S; Stoll BJ; Walsh MC; Higgins RD;
    J Perinatol; 2014 Jan; 34(1):64-70. PubMed ID: 24135709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Healthcare Needs in Extremely Low Birth Weight Infants With NEC and Spontaneous Intestinal Perforation.
    Chugh PV; Nes E; Culbreath K; Keefe G; Edwards EM; Morrow KA; Ehret D; Soll RF; Modi BP; Horbar JD; Jaksic T
    J Pediatr Surg; 2024 Sep; 59(9):1759-1764. PubMed ID: 38561308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants.
    Stavel M; Wong J; Cieslak Z; Sherlock R; Claveau M; Shah PS
    J Perinatol; 2017 Feb; 37(2):188-193. PubMed ID: 27763630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between antenatal indomethacin as a tocolytic drug and neonatal outcomes: a retrospective cohort study.
    Rovers JFJ; Thomissen IJC; Janssen LCE; Lingius S; Wieland BV; Dieleman JP; Niemarkt HJ; van Runnard Heimel PJ
    J Matern Fetal Neonatal Med; 2021 Sep; 34(18):2945-2951. PubMed ID: 31597542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.